APA (7th ed.) Citation

K, N., H, S., H, M., S, M., I, K., K, K., . . . M, S. (2017). Axitinib-induced reversible posterior leukoencephalopathy syndrome in a patient with metastatic renal cell carcinoma. International cancer conference journal, 6(4), 197. https://doi.org/10.1007/s13691-017-0306-x

Chicago Style (17th ed.) Citation

K, Nakamura, et al. "Axitinib-induced Reversible Posterior Leukoencephalopathy Syndrome in a Patient with Metastatic Renal Cell Carcinoma." International Cancer Conference Journal 6, no. 4 (2017): 197. https://doi.org/10.1007/s13691-017-0306-x.

MLA (9th ed.) Citation

K, Nakamura, et al. "Axitinib-induced Reversible Posterior Leukoencephalopathy Syndrome in a Patient with Metastatic Renal Cell Carcinoma." International Cancer Conference Journal, vol. 6, no. 4, 2017, p. 197, https://doi.org/10.1007/s13691-017-0306-x.